Abbott officer plans sale of 27 shares

ABBOTT LABORATORIES (ABT) received a Form 144 notice that John A. McCoy, Jr., identified as an officer, intends to sell 27 shares of common stock under Rule 144.

Rhea-AI Filing Summary

ABBOTT LABORATORIES (ABT) received a Form 144 notice that John A. McCoy, Jr., identified as an officer, intends to sell 27 shares of common stock under Rule 144. The shares come from a restricted stock award that vested on September 1, 2026 and are to be sold on September 2, 2026 through UBS Financial Services, Inc. on the NYSE.

Key Figures

Shares to be sold: 27 shares Vesting date: September 1, 2026 Planned sale date: September 2, 2026

3 metrics

Shares to be sold 27 shares Common stock covered by the Form 144 notice

Vesting date September 1, 2026 Restricted stock award vested before the planned sale

Planned sale date September 2, 2026 Date listed for the sale of the 27 shares

Key Terms

Rule 144, Restricted Stock Award Vested, Attorney-in-Fact

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Award Vested financial

"Common | 09/01/2026 | Restricted Stock Award Vested | Issuer"

Attorney-in-Fact regulatory

"Signature | /s/ John A. McCoy, Jr., by Aaron N. Rice, Attorney-in-Fact"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

What does the Form 144 filing mean for ABBOTT LABORATORIES (ABT)?

The filing states that an Abbott Laboratories officer, John A. McCoy, Jr., intends to sell 27 shares of common stock under Rule 144 after a restricted stock award vested, with the sale planned for September 2, 2026 through UBS Financial Services, Inc. on the NYSE.

How many ABBOTT LABORATORIES (ABT) shares are covered by this Form 144?

The Form 144 covers an intended sale of 27 shares of Abbott Laboratories common stock. These shares are associated with a restricted stock award that vested on September 1, 2026 and are to be sold pursuant to Rule 144.

When were the ABBOTT LABORATORIES (ABT) shares acquired for this Form 144 sale?

The shares are tied to a restricted stock award that vested on September 1, 2026. The Form 144 describes the nature of acquisition as “Restricted Stock Award Vested,” indicating the vesting event as the source of the shares.

On what date are the ABBOTT LABORATORIES (ABT) shares expected to be sold?

The Form 144 indicates that the 27 shares of Abbott Laboratories common stock are expected to be sold on or about September 2, 2026. UBS Financial Services, Inc. is listed as the broker and the NYSE as the trading venue.

Who is the insider involved in this ABBOTT LABORATORIES (ABT) Form 144 filing?

The notice is filed for the account of John A. McCoy, Jr., identified as an officer of Abbott Laboratories. The Form 144 is signed “/s/ John A. McCoy, Jr., by Aaron N. Rice, Attorney-in-Fact,” indicating it was executed under a power of attorney.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 05:18 PM Accepted by SEC EDGAR 09/02/2026 - 05:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001644207
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABBOTT LABORATORIES
SEC File Number	001-02189
Address of Issuer	100 ABBOTT PARK ROAD ABBOTT PARK ILLINOIS 60064
Phone	(224) 667-6100
Name of Person for Whose Account the Securities are To Be Sold	John A. McCoy, Jr.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc. 1000 Harbor Blvd. 3rd Floor Weehawken NJ 07086	27	2957	1730383296	09/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock Award Vested	Issuer			27	09/02/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ John A. McCoy, Jr., by Aaron N. Rice, Attorney-in-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)